CNP blocks mitochondrial depolarization and inhibits SARS-CoV-2 replication in vitro and in vivo.

"plos publication stage vor-update-to-uncorrected-proof publication update 2024-01-04 data availability all data for this manuscript is available at the center for open science at https://osf io/f6db3/ .; outbreaks covid-19 data availability all data for this manuscript is available at the center for open science at https://osf io/f6db3/ . data availability all data for this manuscript is available at the center for open science at https://osf"

"I have read the journal’s policy and the authors of this manuscript have the following competing interests: M.B.F. is on the scientific advisory board of Aikido Pharma and has collaborative research agreements with Novavax, AstraZeneca, Regeneron, and Irazu Bio. These do not have any effect on the planning or interpretations of the work presented in this manuscript."

"This work is partially funded by NIH R01 AI148166 (to MBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."